3 Trademark Results found for "e therapeutics"

Also try searching for:

e therapeutics*

e th*

*ics

e *cs

Details	Status	Class/Description
e therapeutics E-THERAPEUTICS PLC UK00003805809	Registered	Pharmaceutical and medical preparations; pharmaceutical and medical pr... Class 005 Class 005 Pharmaceutical Products Pharmaceutical and medical preparations; pharmaceutical and medical preparations for use in targeting genes and silencing or inhibiting gene expression; RNAi-based medicines and pharmaceuticals; short interfering RNA (siRNA) medicines and pharmaceuticals; nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation; none of the aforementioned goods for, or related to, T-cells or T-cell receptors. Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Computer software; downloadable computer software; computer software for use in the field of pharmaceuticals, medicines and drug discovery; artificial intelligence and machine learning software; artificial intelligence and machine learning software for use in the field of pharmaceuticals, medicines and drug discovery; databases; electronic databases for use in the field of pharmaceuticals, medicines and drug discovery; computer platform software; computer software platforms; computer platform software platforms for use in the field of pharmaceuticals, medicines and drug discovery; computer software platforms for use in the field of pharmaceuticals, medicines and drug discovery; none of the aforementioned goods for, or related to, T-cells or T-cell receptors. ... Class 040 Treatment & Processing of Materials Services Custom manufacture of pharmaceutical and medical preparations; custom manufacture of pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; custom manufacture of RNAi-based pharmaceuticals and medicines; custom manufacture of short interfering RNA (siRNA) medicines; custom manufacture of nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; custom manufacture of pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid; none of the aforementioned services for, or related to, T-cells or T-cell receptors. Class 042 Computer & Software Services & Scientific Services Scientific research and development; pharmaceutical research and development services; scientific research and development in the field of targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to RNAi-based pharmaceuticals and medicines; scientific, pharmaceutical and medical research and development services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking gene expression, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and, pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; drug discovery services; drug discovery services relating to RNAi-based pharmaceuticals and medicines; drug discovery services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; drug discovery services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; genetic research; scientific and technical data analysis; scientific and technical data analysis in relation to pharmaceuticals and medicines; scientific and technical data analysis in relation to RNAi-based medicines; scientific and technical data analysis in relation to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific and technical data analysis in relation to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; design, development, creation and maintenance of computer platforms and computer software; design, development, creation and maintenance of computational platforms; design, development, creation and maintenance of computer platforms and computer software for use in the field of pharmaceuticals, medicines and drug discovery; Platform as a Service (PaaS); Platform as a Service (PaaS) services relating to the use of artificial intelligence and machine learning software and databases in the field of pharmaceuticals, medicines and drug discovery; Platform as a Service (PaaS) services relating to the use of artificial intelligence and machine learning software and databases in relation to RNAi-based medicines and pharmaceuticals, short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; design and development of computer-simulated models; design of computer-simulated models for use in the field of pharmaceuticals, medicines and drug discovery; non-downloadable computer software; non-downloadable computer software for use in the field of pharmaceuticals, medicines and drug discovery; Software as a Service (SaaS); Software as a Service (SaaS) services relating to the use of artificial intelligence and machine learning software and databases in the field of pharmaceuticals, medicines and drug discovery; Software as a Service (SaaS) services relating to the use of artificial intelligence and machine learning in relation to RNAi-based medicines and pharmaceuticals, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid; none of the aforementioned services for, or related to, T-cells or T-cell receptors.
e-therapeutics E-THERAPEUTICS PLC UK00003805804	Registered	Pharmaceutical and medical preparations; pharmaceutical and medical pr... Class 005 Class 005 Pharmaceutical Products Pharmaceutical and medical preparations; pharmaceutical and medical preparations for use in targeting genes and silencing or inhibiting gene expression; RNAi-based medicines and pharmaceuticals; short interfering RNA (siRNA) medicines and pharmaceuticals; nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation; none of the aforementioned goods for, or related to, T-cells or T-cell receptors. Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Computer software; downloadable computer software; computer software for use in the field of pharmaceuticals, medicines and drug discovery; artificial intelligence and machine learning software; artificial intelligence and machine learning software for use in the field of pharmaceuticals, medicines and drug discovery; databases; electronic databases for use in the field of pharmaceuticals, medicines and drug discovery; computer platform software; computer software platforms; computer platform software platforms for use in the field of pharmaceuticals, medicines and drug discovery; computer software platforms for use in the field of pharmaceuticals, medicines and drug discovery; none of the aforementioned goods for, or related to, T-cells or T-cell receptors. ... Class 040 Treatment & Processing of Materials Services Custom manufacture of pharmaceutical and medical preparations; custom manufacture of pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; custom manufacture of RNAi-based pharmaceuticals and medicines; custom manufacture of short interfering RNA (siRNA) medicines; custom manufacture of nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; custom manufacture of pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid; none of the aforementioned services for, or related to, T-cells or T-cell receptors. Class 042 Computer & Software Services & Scientific Services Scientific research and development; pharmaceutical research and development services; scientific research and development in the field of targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to RNAi-based pharmaceuticals and medicines; scientific, pharmaceutical and medical research and development services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking gene expression, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and, pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; drug discovery services; drug discovery services relating to RNAi-based pharmaceuticals and medicines; drug discovery services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; drug discovery services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; genetic research; scientific and technical data analysis; scientific and technical data analysis in relation to pharmaceuticals and medicines; scientific and technical data analysis in relation to RNAi-based medicines; scientific and technical data analysis in relation to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific and technical data analysis in relation to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; design, development, creation and maintenance of computer platforms and computer software; design, development, creation and maintenance of computational platforms; design, development, creation and maintenance of computer platforms and computer software for use in the field of pharmaceuticals, medicines and drug discovery; Platform as a Service (PaaS); Platform as a Service (PaaS) services relating to the use of artificial intelligence and machine learning software and databases in the field of pharmaceuticals, medicines and drug discovery; Platform as a Service (PaaS) services relating to the use of artificial intelligence and machine learning software and databases in relation to RNAi-based medicines and pharmaceuticals, short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; design and development of computer-simulated models; design of computer-simulated models for use in the field of pharmaceuticals, medicines and drug discovery; non-downloadable computer software; non-downloadable computer software for use in the field of pharmaceuticals, medicines and drug discovery; Software as a Service (SaaS); Software as a Service (SaaS) services relating to the use of artificial intelligence and machine learning software and databases in the field of pharmaceuticals, medicines and drug discovery; Software as a Service (SaaS) services relating to the use of artificial intelligence and machine learning in relation to RNAi-based medicines and pharmaceuticals, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid; none of the aforementioned services for, or related to, T-cells or T-cell receptors.
e echo THERAPEUTICS Echo Therapeutics, Inc. UK00911719663	Dead	Pharmaceuticals; pharmaceuticals, namely, pharmaceutical preparations ... Class 001 Class 001 Chemical Products Chemicals, namely, penetration enhancers for use with chemicals, diagnostic, cosmetic, therapeutic and fungicidal agents. Class 005 Class 005 Pharmaceutical Products Pharmaceuticals; pharmaceuticals, namely, pharmaceutical preparations for treating skin disorders.

Registered

e therapeutics

E-THERAPEUTICS PLC

005

009

...

Class 040

Treatment & Processing of Materials Services

Custom manufacture of pharmaceutical and medical preparations; custom manufacture of pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; custom manufacture of RNAi-based pharmaceuticals and medicines; custom manufacture of short interfering RNA (siRNA) medicines; custom manufacture of nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; custom manufacture of pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid; none of the aforementioned services for, or related to, T-cells or T-cell receptors.

Class 042

Computer & Software Services & Scientific Services

Scientific research and development; pharmaceutical research and development services; scientific research and development in the field of targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to RNAi-based pharmaceuticals and medicines; scientific, pharmaceutical and medical research and development services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking gene expression, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and, pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; drug discovery services; drug discovery services relating to RNAi-based pharmaceuticals and medicines; drug discovery services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; drug discovery services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; genetic research; scientific and technical data analysis; scientific and technical data analysis in relation to pharmaceuticals and medicines; scientific and technical data analysis in relation to RNAi-based medicines; scientific and technical data analysis in relation to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific and technical data analysis in relation to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; design, development, creation and maintenance of computer platforms and computer software; design, development, creation and maintenance of computational platforms; design, development, creation and maintenance of computer platforms and computer software for use in the field of pharmaceuticals, medicines and drug discovery; Platform as a Service (PaaS); Platform as a Service (PaaS) services relating to the use of artificial intelligence and machine learning software and databases in the field of pharmaceuticals, medicines and drug discovery; Platform as a Service (PaaS) services relating to the use of artificial intelligence and machine learning software and databases in relation to RNAi-based medicines and pharmaceuticals, short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; design and development of computer-simulated models; design of computer-simulated models for use in the field of pharmaceuticals, medicines and drug discovery; non-downloadable computer software; non-downloadable computer software for use in the field of pharmaceuticals, medicines and drug discovery; Software as a Service (SaaS); Software as a Service (SaaS) services relating to the use of artificial intelligence and machine learning software and databases in the field of pharmaceuticals, medicines and drug discovery; Software as a Service (SaaS) services relating to the use of artificial intelligence and machine learning in relation to RNAi-based medicines and pharmaceuticals, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid; none of the aforementioned services for, or related to, T-cells or T-cell receptors.

Pharmaceutical and medical preparations; pharmaceutical and medical pr...

Registered

e-therapeutics

E-THERAPEUTICS PLC

005

009

...

Class 040

Treatment & Processing of Materials Services

Class 042

Computer & Software Services & Scientific Services

Pharmaceutical and medical preparations; pharmaceutical and medical pr...

Dead

e echo THERAPEUTICS

Echo Therapeutics, Inc.

001

005

Pharmaceuticals; pharmaceuticals, namely, pharmaceutical preparations ...

Owners

Etherapeutics plc (2)

Echo therapeutics inc. (1)

Categories

Class 5 (3)

Class 9 (2)

Class 40 (2)

Class 42 (2)

Class 1 (1)

Attorney

Cms cameron mckenna nabarro olswang llp (2)

Forresters ip llp (1)

Correspondents

Cannon place (2)

The gherkin (11th floor) (1)

Display

List View

Grid View

Apply for Trade Mark

Select countries to protect your logo Trade Mark

Trade Mark Name

Country Selected

United Kingdom

£249/ 1 class + gov fee

United States

£74/ 1 class + gov fee

Canada

£297/ 1 class + gov fee

Mexico

£371/ 1 class + gov fee

European Union

£521/ 1 class + gov fee

China

£371/ 1 class + gov fee

South Korea

£520/ 1 class + gov fee

Japan

£594/ 1 class + gov fee

India

£186/ 1 class + gov fee

United Kingdom

£249/ 1 class + gov fee

Australia

£223/ 1 class + gov fee

Israel

£520/ 1 class + gov fee

United Arab Emirates

£520/ 1 class + gov fee

New Zealand

£297/ 1 class + gov fee

Brazil

£371/ 1 class + gov fee

Taiwan

£594/ 1 class + gov fee

Ukraine

£594/ 1 class + gov fee

Indonesia

£520/ 1 class + gov fee

South Africa

£371/ 1 class + gov fee

Singapore

£594/ 1 class + gov fee

Saudi Arabia

£594/ 1 class + gov fee

Afghanistan

£594/ 1 class + gov fee

Algeria

£594/ 1 class + gov fee

Argentina

£297/ 1 class + gov fee

Austria

£669/ 1 class + gov fee

Bahrain

£520/ 1 class + gov fee

Bangladesh

£446/ 1 class + gov fee

Benelux

£743/ 1 class + gov fee

Bhutan

£669/ 1 class + gov fee

Bolivia

£594/ 1 class + gov fee

Botswana

£966/ 1 class + gov fee

British Virgin Islands

£891/ 1 class + gov fee

Bulgaria

£594/ 1 class + gov fee

Cambodia

£594/ 1 class + gov fee

Chile

£371/ 1 class + gov fee

Colombia

£520/ 1 class + gov fee

Congo

£891/ 1 class + gov fee

Costa Rica

£669/ 1 class + gov fee

Croatia

£669/ 1 class + gov fee

Cyprus

£743/ 1 class + gov fee

Czech Republic

£669/ 1 class + gov fee

Denmark

£594/ 1 class + gov fee

Aruba

£891/ 1 class + gov fee

Dominican Republic

£669/ 1 class + gov fee

Curacao

£891/ 1 class + gov fee

Macau

£520/ 1 class + gov fee

Greenland

£594/ 1 class + gov fee

Ecuador

£594/ 1 class + gov fee

Egypt

£520/ 1 class + gov fee

El Salvador

£594/ 1 class + gov fee

Ethiopia

£817/ 1 class + gov fee

France

£669/ 1 class + gov fee

Gaza

£594/ 1 class + gov fee

Germany

£669/ 1 class + gov fee

Greece

£594/ 1 class + gov fee

Guatemala

£669/ 1 class + gov fee

Haiti

£669/ 1 class + gov fee

Honduras

£669/ 1 class + gov fee

Hong Kong (SAR)

£669/ 1 class + gov fee

Hungary

£817/ 1 class + gov fee

Iraq

£1,114/ 1 class + gov fee

Italy

£669/ 1 class + gov fee

Jordan

£594/ 1 class + gov fee

Kazakhstan

£594/ 1 class + gov fee

Kenya

£669/ 1 class + gov fee

Kuwait

£594/ 1 class + gov fee

Laos

£520/ 1 class + gov fee

Lebanon

£743/ 1 class + gov fee

Lesotho

£891/ 1 class + gov fee

Libya

£669/ 1 class + gov fee

Madrid Protocol (WIPO)

£1,486/ 1 class + gov fee

Malawi

£817/ 1 class + gov fee

Malaysia

£520/ 1 class + gov fee

Maldives

£743/ 1 class + gov fee

Morocco

£743/ 1 class + gov fee

Mozambique

£669/ 1 class + gov fee

Myanmar

£594/ 1 class + gov fee

Namibia

£594/ 1 class + gov fee

Nepal

£520/ 1 class + gov fee

Nicaragua

£669/ 1 class + gov fee

Norway

£669/ 1 class + gov fee

Oman

£817/ 1 class + gov fee

Pakistan

£594/ 1 class + gov fee

Panama

£669/ 1 class + gov fee

Paraguay

£669/ 1 class + gov fee

Peru

£594/ 1 class + gov fee

Philippines

£669/ 1 class + gov fee

Poland

£371/ 1 class + gov fee

Portugal

£669/ 1 class + gov fee

Puerto Rico

£669/ 1 class + gov fee

Qatar

£594/ 1 class + gov fee

Romania

£669/ 1 class + gov fee

Serbia

£669/ 1 class + gov fee

Slovakia

£669/ 1 class + gov fee

Spain

£669/ 1 class + gov fee

Sri Lanka

£520/ 1 class + gov fee

Swaziland

£966/ 1 class + gov fee

Sweden

£594/ 1 class + gov fee

Switzerland

£669/ 1 class + gov fee

Thailand

£594/ 1 class + gov fee

Tunisia

£669/ 1 class + gov fee

Turkey

£594/ 1 class + gov fee

Uganda

£520/ 1 class + gov fee

United Republic of Tanzania

£520/ 1 class + gov fee

Uruguay

£594/ 1 class + gov fee

Venezuela

£669/ 1 class + gov fee

Vietnam

£594/ 1 class + gov fee

West Bank, Palestine

£594/ 1 class + gov fee

Yemen

£1,263/ 1 class + gov fee

Albania

£669/ 1 class + gov fee

Andorra

£669/ 1 class + gov fee

Angola

£966/ 1 class + gov fee

Antigua and Barbuda

£891/ 1 class + gov fee

Armenia

£594/ 1 class + gov fee

Azerbaijan

£594/ 1 class + gov fee

Bahamas

£1,040/ 1 class + gov fee

Barbados

£966/ 1 class + gov fee

Belgium

£743/ 1 class + gov fee

Belize

£966/ 1 class + gov fee

Benin

£594/ 1 class + gov fee

Bosnia and Herzegovina

£743/ 1 class + gov fee

Brunei

£966/ 1 class + gov fee

Burkina Faso

£594/ 1 class + gov fee

Burundi

£891/ 1 class + gov fee

Cabo Verde

£669/ 1 class + gov fee

Cameroon

£594/ 1 class + gov fee

Central African Republic (CAR)

£594/ 1 class + gov fee

Chad

£594/ 1 class + gov fee

Comoros

£594/ 1 class + gov fee

Cote d'Ivoire

£594/ 1 class + gov fee

Czechia

£743/ 1 class + gov fee

Djibouti

£891/ 1 class + gov fee

Dominica

£966/ 1 class + gov fee

Equatorial Guinea

£594/ 1 class + gov fee

Eritrea

£743/ 1 class + gov fee

Estonia

£966/ 1 class + gov fee

Eswatini

£966/ 1 class + gov fee

Fiji

£669/ 1 class + gov fee

Finland

£520/ 1 class + gov fee

Gabon

£594/ 1 class + gov fee

Gambia

£669/ 1 class + gov fee

Georgia

£594/ 1 class + gov fee

Ghana

£743/ 1 class + gov fee

Grenada

£966/ 1 class + gov fee

Guinea

£594/ 1 class + gov fee

Guinea-Bissau

£594/ 1 class + gov fee

Guyana

£966/ 1 class + gov fee

Iceland

£966/ 1 class + gov fee

Ireland

£594/ 1 class + gov fee

Jamaica

£891/ 1 class + gov fee

Kiribati

£743/ 1 class + gov fee

Kosovo

£669/ 1 class + gov fee

Kyrgyzstan

£669/ 1 class + gov fee

Latvia

£520/ 1 class + gov fee

Liberia

£743/ 1 class + gov fee

Liechtenstein

£743/ 1 class + gov fee

Lithuania

£520/ 1 class + gov fee

Luxembourg

£743/ 1 class + gov fee

Madagascar

£743/ 1 class + gov fee

Mali

£594/ 1 class + gov fee

Malta

£446/ 1 class + gov fee

Marshall Islands

£743/ 1 class + gov fee

Mauritania

£594/ 1 class + gov fee

Mauritius

£743/ 1 class + gov fee

Micronesia

£743/ 1 class + gov fee

Moldova

£743/ 1 class + gov fee

Monaco

£1,040/ 1 class + gov fee

Mongolia

£446/ 1 class + gov fee

Montenegro

£669/ 1 class + gov fee

Nauru

£743/ 1 class + gov fee

Netherlands

£743/ 1 class + gov fee

Niger

£594/ 1 class + gov fee

Nigeria

£297/ 1 class + gov fee

North Macedonia

£669/ 1 class + gov fee

Palau

£743/ 1 class + gov fee

Palestine

£743/ 1 class + gov fee

Papua New Guinea

£594/ 1 class + gov fee

Rwanda

£743/ 1 class + gov fee

Saint Kitts and Nevis

£966/ 1 class + gov fee

Saint Lucia

£966/ 1 class + gov fee

Saint Vincent and the Grenadines

£966/ 1 class + gov fee

Samoa

£891/ 1 class + gov fee

San Marino

£743/ 1 class + gov fee

Sao Tome and Principe

£743/ 1 class + gov fee

Senegal

£594/ 1 class + gov fee

Seychelles

£743/ 1 class + gov fee

Sierra Leone

£743/ 1 class + gov fee

Slovenia

£669/ 1 class + gov fee

Solomon Islands

£743/ 1 class + gov fee

Somalia

£743/ 1 class + gov fee

South Sudan

£743/ 1 class + gov fee

Suriname

£1,189/ 1 class + gov fee

Tajikistan

£594/ 1 class + gov fee

Tanzania

£520/ 1 class + gov fee

Timor-Leste

£743/ 1 class + gov fee

Togo

£594/ 1 class + gov fee

Tonga

£966/ 1 class + gov fee

Trinidad and Tobago

£891/ 1 class + gov fee

Turkmenistan

£594/ 1 class + gov fee

Tuvalu

£743/ 1 class + gov fee

Uzbekistan

£520/ 1 class + gov fee

Vanuatu

£891/ 1 class + gov fee

Zambia

£669/ 1 class + gov fee

Zimbabwe

£669/ 1 class + gov fee

OAPI

£669/ 1 class + gov fee

ARIPO

£743/ 1 class + gov fee

End of search results

Page 1 of 1